-
Something wrong with this record ?
Changes in disease burden and epidemiological transitions
G. Gulis, R. Zidkova, Z. Meier
Language English Country England, Great Britain
Document type Journal Article
NLK
Directory of Open Access Journals
from 2011
Free Medical Journals
from 2011
PubMed Central
from 2011
Europe PubMed Central
from 2011
ProQuest Central
from 2021-01-01
Open Access Digital Library
from 2011-01-01
Open Access Digital Library
from 2011-01-01
Health & Medicine (ProQuest)
from 2021-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2011
Springer Nature OA/Free Journals
from 2011-12-01
Springer Nature - nature.com Journals - Fully Open Access
from 2011-12-01
- MeSH
- Global Health MeSH
- Chronic Disease epidemiology MeSH
- Global Burden of Disease * MeSH
- Humans MeSH
- Cost of Illness MeSH
- Disability-Adjusted Life Years MeSH
- Risk Factors MeSH
- Check Tag
- Humans MeSH
- Male MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
The epidemiological transition has been characterized by demographic, societal and health changes in societies. Presuming that acute diseases, mostly of communicable etiology, are more important in terms of early-life mortality, whereas chronic diseases are responsible for a greater burden of disease throughout the life course, we attempt to develop an index to measure the stage of the epidemiological transition. Using Global Burden of Diseases, Risk Factors and Injuries (GBD) data available at https://vizhub.healthdata.org/gbd-compare/ on 04/04/2024 to calculate the Epidemiologic Transition Estimate (ETE) index as a ratio of YLD/YLL for the time period of 1990-2019. The values of the index ranged from 0.131 to 1.067 and 0.180 to 2.108 for males and females, respectively, across the 195 included countries. The transition process seems to be faster to females compared to males. The index shows consistently increasing values for five SDI-based country groups, with clear differences among the groups. Although more research and validation studies are needed despite all the uncertainties, the index seems to be robust to assess the progress in epidemiological transition. These findings can help to predict future social care and health system needs to address causes leading to YLD or YLL.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25009482
- 003
- CZ-PrNML
- 005
- 20250429135304.0
- 007
- ta
- 008
- 250415s2025 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1038/s41598-025-94050-w $2 doi
- 035 __
- $a (PubMed)40089633
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Gulis, Gabriel $u Unit for Health Promotion Research, University of Southern Denmark, Degnevej 14, 6700, Esbjerg, Denmark. ggulis@health.sdu.dk $u Olomouc University Social Health Institute (OUSHI), Palacky University Olomouc, Katerinska 653/17, 77900, Olomouc, Czech Republic. ggulis@health.sdu.dk
- 245 10
- $a Changes in disease burden and epidemiological transitions / $c G. Gulis, R. Zidkova, Z. Meier
- 520 9_
- $a The epidemiological transition has been characterized by demographic, societal and health changes in societies. Presuming that acute diseases, mostly of communicable etiology, are more important in terms of early-life mortality, whereas chronic diseases are responsible for a greater burden of disease throughout the life course, we attempt to develop an index to measure the stage of the epidemiological transition. Using Global Burden of Diseases, Risk Factors and Injuries (GBD) data available at https://vizhub.healthdata.org/gbd-compare/ on 04/04/2024 to calculate the Epidemiologic Transition Estimate (ETE) index as a ratio of YLD/YLL for the time period of 1990-2019. The values of the index ranged from 0.131 to 1.067 and 0.180 to 2.108 for males and females, respectively, across the 195 included countries. The transition process seems to be faster to females compared to males. The index shows consistently increasing values for five SDI-based country groups, with clear differences among the groups. Although more research and validation studies are needed despite all the uncertainties, the index seems to be robust to assess the progress in epidemiological transition. These findings can help to predict future social care and health system needs to address causes leading to YLD or YLL.
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 12
- $a globální zátěž nemocemi $7 D000071219
- 650 _2
- $a rizikové faktory $7 D012307
- 650 _2
- $a chronická nemoc $x epidemiologie $7 D002908
- 650 _2
- $a osobní újma zaviněná nemocí $7 D017281
- 650 _2
- $a celosvětové zdraví $7 D014943
- 650 _2
- $a počet let života s onemocněním $7 D000087509
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Zidkova, Radka $u Olomouc University Social Health Institute (OUSHI), Palacky University Olomouc, Katerinska 653/17, 77900, Olomouc, Czech Republic
- 700 1_
- $a Meier, Zdenek $u Olomouc University Social Health Institute (OUSHI), Palacky University Olomouc, Katerinska 653/17, 77900, Olomouc, Czech Republic
- 773 0_
- $w MED00182195 $t Scientific reports $x 2045-2322 $g Roč. 15, č. 1 (2025), s. 8961
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/40089633 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20250415 $b ABA008
- 991 __
- $a 20250429135300 $b ABA008
- 999 __
- $a ok $b bmc $g 2311081 $s 1246563
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2025 $b 15 $c 1 $d 8961 $e 20250315 $i 2045-2322 $m Scientific reports $n Sci Rep $x MED00182195
- LZP __
- $a Pubmed-20250415